Conexeu Sciences, Inc. (CNXU)
6.25
-0.92
(-12.89%)
USD |
NASDAQ |
Sep 01, 14:04
Conexeu Sciences Total Long Term Debt (Quarterly) : 0.00 for April 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | 0.00 |
| January 31, 2026 | 0.00 |
| October 31, 2025 | 0.00 |
| Date | Value |
|---|---|
| April 30, 2025 | 0.00 |
| October 31, 2024 | 0.0981M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| AbbVie, Inc. | 70.82B |
| Vericel Corp. | 80.41M |
| ACADIA Pharmaceuticals, Inc. | 59.55M |
| Alnylam Pharmaceuticals, Inc. | 2.942B |
| Anika Therapeutics, Inc. | 23.32M |